|
Comprehensive analysis of tumor NGS data to demonstrate pathways pointing to therapeutic targeting options. |
|
|
Employment - Ashion Analytics; Human Longevity, Inc |
|
|
Employment - Human Longevity, Inc |
|
|
Employment - Human Longevity, Inc |
|
|
Employment - Human Longevity, Inc |
Stock and Other Ownership Interests - Human Longevity, Inc |
Honoraria - Human Longevity, Inc |
Research Funding - Human Longevity, Inc |
Travel, Accommodations, Expenses - Human Longevity, Inc |
Other Relationship - Human Longevity, Inc (I) |
|
|
Employment - Human Longevity, Inc |
Stock and Other Ownership Interests - Human Longevity, Inc |
|
|
No Relationships to Disclose |
|
|
Employment - Human Longevity, Inc |
|
|
No Relationships to Disclose |
|
|
Employment - Human Longevity, Inc |
|
|
Employment - Human Longevity, Inc |
|
|
Employment - Human Longevity, Inc |
|
|
Employment - Human Longevity, Inc |
Stock and Other Ownership Interests - Human Longevity, Inc |
|
|
Employment - Human Longevity, Inc |
Stock and Other Ownership Interests - Human Longevity, Inc |
Research Funding - Human Longevity, Inc |
Patents, Royalties, Other Intellectual Property - Abbott Laboratories |
|
|
Employment - Human Longevity, Inc |
|
|
Employment - Human Longevity, Inc |
Leadership - Human Longevity, Inc |
Stock and Other Ownership Interests - Human Longevity, Inc |
|
Consulting or Advisory Role - Oliver Wyman; OxStem |
Research Funding - Human Longevity, Inc |
Travel, Accommodations, Expenses - Human Longevity, Inc |
Other Relationship - Human Longevity, Inc |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Human Longevity, Inc; Merck; Pfizer |
Speakers' Bureau - Bayer; Eisai |
|
|
Employment - Human Longevity, Inc |
Leadership - Human Longevity, Inc |
Honoraria - Bristol-Myers Squibb; Merck; Roche |
Consulting or Advisory Role - Bristol-Myers Squibb; Human Longevity, Inc |
Speakers' Bureau - Genentech; Roche |